IL17A and nasopharyngeal carcinoma: These findings were replicated in the validation cohort, where 58.3% (14/24) of PC group samples showed IL-17A <1 pg/ml compared with 32.0% (8/25) in the NPC group (Fisher's exact test p = 0.031).